Suspending IP Protection: A Bad Idea (That Won't Achieve Its Desired Goals)

Published date28 April 2021
Subject MatterTrade Secrets,Life Sciences,Misappropriation,Vaccinations,Supply Chain,Legislative Agendas,Infectious Diseases,Intellectual Property Protection,Pharmaceutical Industry,Coronavirus/COVID-19
AuthorKevin Noonan
Law FirmMcDonnell Boehnen Hulbert & Berghoff LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT